PPARGC1A and Alzheimer disease: PGC1α protein levels were reduced in brains of the Tg2576 (overexpressing APP with the familiar Swedish mutation) and APP/PS1 (which also include presenilin mutations) mouse models [31,32], as well as in nuclear extracts from human AD patients [33].